4-Chloro-N-(2-methyl-3-oxo-2,3-dihydro-1,2,4-thiadiazol-5-yl)benzamide

Catalog No. :
ACAQGJ253
CAS No. :
138712-84-2
Molecular Formula :
C10H8ClN3O2S
Molecular Weight :
269.71

IUPAC Name:4-chloro-N-(2-methyl-3-oxo-2,3-dihydro-1,2,4-thiadiazol-5-yl)benzamide

4-Chloro-N-(2-methyl-3-oxo-2,3-dihydro-1,2,4-thiadiazol-5-yl)benzamide structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
1g90%$321.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name4-Chloro-N-(2-methyl-3-oxo-2,3-dihydro-1,2,4-thiadiazol-5-yl)benzamide
IUPAC Name4-chloro-N-(2-methyl-3-oxo-2,3-dihydro-1,2,4-thiadiazol-5-yl)benzamide
MDL No.MFCD00141737
Molecular FormulaC10H8ClN3O2S
Molecular Weight269.71
SMILESO=C(NC(SN1C)=NC1=O)C2=CC=C(Cl)C=C2
InChI KeyFXTKGKYCIMVYSO-UHFFFAOYSA-N
Synonym4-CHLORO-N-(2-METHYL-3-OXO-2,3-DIHYDRO-1,2,4-THIADIAZOL-5-YL)BENZENECARBOXAMIDE;4-chloro-N-(2-methyl-3-oxo-2,3-dihydro-1,2,4-thiadiazol-5-yl)benzamide;Benzamide, 4-chloro-N-(2,3-dihydro-2-methyl-3-oxo-1,2,4-thiadiazol-5-yl)-
CAS No.138712-84-2

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P264-P270-P271-P280-P302+P352-P304+P340-P305+P351+P338-P312-P330-P362-P403+P233-P501

Synthetic Route by SureRoute

1. ACAQGJ253 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACAQGJ253 route product structure diagram
    ACAQGJ253138712-84-2
Inquiry

2. ACAQGJ253 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACAQGJ253 route product structure diagram
    ACAQGJ253138712-84-2
Inquiry

Comments (0)